_version_ 1868266149496487937
author Shahlaei, Mona
Afkhami, Hamed
Ahmadieh-Yazdi, Amirhossein
Mirmazloumi, Seyed Hashem
Sahraei, Seyedeh Saeideh
Akbari, Mohammad
Yang, Piao
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Sundararaman, Aravind
Mohan, Sreedivya
Sheykhhasan, Mohsen
Al-Musawi, Sharafaldin
Dama, Paola
author_facet Shahlaei, Mona
Afkhami, Hamed
Ahmadieh-Yazdi, Amirhossein
Mirmazloumi, Seyed Hashem
Sahraei, Seyedeh Saeideh
Akbari, Mohammad
Yang, Piao
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Sundararaman, Aravind
Mohan, Sreedivya
Sheykhhasan, Mohsen
Al-Musawi, Sharafaldin
Dama, Paola
Shahlaei, Mona
Afkhami, Hamed
Ahmadieh-Yazdi, Amirhossein
Mirmazloumi, Seyed Hashem
Sahraei, Seyedeh Saeideh
Akbari, Mohammad
Yang, Piao
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Sundararaman, Aravind
Mohan, Sreedivya
Sheykhhasan, Mohsen
Al-Musawi, Sharafaldin
Dama, Paola
collection PubMed - marine biology
contents Exosomes in Alzheimer's disease: From pathogenesis to therapeutics-A comprehensive review of diagnostic and drug delivery applications. Shahlaei, Mona Afkhami, Hamed Ahmadieh-Yazdi, Amirhossein Mirmazloumi, Seyed Hashem Sahraei, Seyedeh Saeideh Akbari, Mohammad Yang, Piao Manoochehri, Hamed Tanzadehpanah, Hamid Mahaki, Hanie Sundararaman, Aravind Mohan, Sreedivya Sheykhhasan, Mohsen Al-Musawi, Sharafaldin Dama, Paola Alzheimer Disease Exosomes Humans Drug Delivery Systems Animals Biomarkers Amyloid beta-Peptides Blood-Brain Barrier Neuroprotective Agents Alzheimer's disease (AD) is still a major unmet medical challenge, with limited treatment options and a critical need for early diagnostics. Exosomes, nanoscale extracellular vesicles with a lipid bilayer, are pivotal players in intercellular communication and promising tools for AD management. Their unique ability to cross the bloodbrain barrier, low immunogenicity, and ability for cargo delivery make them ideal candidates for targeted drug delivery. This review comprehensively examines the biology of exosomes-including their structure, biogenesis, release, and uptake-and evaluates advanced methods for their isolation, purification, and characterization. We highlight their dual role in AD pathogenesis, where they can propagate pathological proteins such as amyloid-β and tau, and in therapeutic applications, where engineered exosomes deliver neuroprotective agents. Furthermore, exosomal biomarkers in biofluids show significant potential for noninvasive early diagnosis. Recent advances in loading strategies and surface engineering have been discussed, alongside challenges in scalability and safety. This synthesis bridges current knowledge with future directions, emphasizing the translational potential of exosomes in AD therapeutics and diagnostics.
format Artículo científico
id pubmed_40987204
institution PubMed
language en
publishDate 2025
publisher Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
record_format pubmed
spellingShingle Exosomes in Alzheimer's disease: From pathogenesis to therapeutics-A comprehensive review of diagnostic and drug delivery applications.
Shahlaei, Mona
Afkhami, Hamed
Ahmadieh-Yazdi, Amirhossein
Mirmazloumi, Seyed Hashem
Sahraei, Seyedeh Saeideh
Akbari, Mohammad
Yang, Piao
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Sundararaman, Aravind
Mohan, Sreedivya
Sheykhhasan, Mohsen
Al-Musawi, Sharafaldin
Dama, Paola
Alzheimer Disease
Exosomes
Humans
Drug Delivery Systems
Animals
Biomarkers
Amyloid beta-Peptides
Blood-Brain Barrier
Neuroprotective Agents
Exosomes in Alzheimer's disease: From pathogenesis to therapeutics-A comprehensive review of diagnostic and drug delivery applications. Shahlaei, Mona Afkhami, Hamed Ahmadieh-Yazdi, Amirhossein Mirmazloumi, Seyed Hashem Sahraei, Seyedeh Saeideh Akbari, Mohammad Yang, Piao Manoochehri, Hamed Tanzadehpanah, Hamid Mahaki, Hanie Sundararaman, Aravind Mohan, Sreedivya Sheykhhasan, Mohsen Al-Musawi, Sharafaldin Dama, Paola Alzheimer Disease Exosomes Humans Drug Delivery Systems Animals Biomarkers Amyloid beta-Peptides Blood-Brain Barrier Neuroprotective Agents Alzheimer's disease (AD) is still a major unmet medical challenge, with limited treatment options and a critical need for early diagnostics. Exosomes, nanoscale extracellular vesicles with a lipid bilayer, are pivotal players in intercellular communication and promising tools for AD management. Their unique ability to cross the bloodbrain barrier, low immunogenicity, and ability for cargo delivery make them ideal candidates for targeted drug delivery. This review comprehensively examines the biology of exosomes-including their structure, biogenesis, release, and uptake-and evaluates advanced methods for their isolation, purification, and characterization. We highlight their dual role in AD pathogenesis, where they can propagate pathological proteins such as amyloid-β and tau, and in therapeutic applications, where engineered exosomes deliver neuroprotective agents. Furthermore, exosomal biomarkers in biofluids show significant potential for noninvasive early diagnosis. Recent advances in loading strategies and surface engineering have been discussed, alongside challenges in scalability and safety. This synthesis bridges current knowledge with future directions, emphasizing the translational potential of exosomes in AD therapeutics and diagnostics.
title Exosomes in Alzheimer's disease: From pathogenesis to therapeutics-A comprehensive review of diagnostic and drug delivery applications.
topic Alzheimer Disease
Exosomes
Humans
Drug Delivery Systems
Animals
Biomarkers
Amyloid beta-Peptides
Blood-Brain Barrier
Neuroprotective Agents
url https://pubmed.ncbi.nlm.nih.gov/40987204/